SCHEMBL4900527

SCHEMBL4900527

CCc1ccc(S(=O)(=O)N(CC)c2csc(-c3ccc(F)cc3)n2)cc1C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
TP53 P04637 3/20 0.41
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
LMNA P02545 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HPGD P15428 1/20 0.37
AVPR1B P47901 1/20 0.36
NPC1 O15118 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SENP8 Q96LD8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897618 0.92 TP53 (0.42) MAPTTP53ALDH1A1TSHRPSEN1
SCHEMBL4902584 0.91 MAPT (0.43) MAPTTP53ALDH1A1TSHRPSEN1
SCHEMBL4898009 0.90 LMNA (0.46) MAPTTP53ALDH1A1TSHRLMNA
SCHEMBL4911850 0.89 ALDH1A1 (0.39) MAPTALDH1A1TSHRPSEN1PSEN2
SCHEMBL4906187 0.89 ALDH1A1 (0.39) MAPTTP53ALDH1A1TSHRKDM4E
SCHEMBL4902485 0.86 TP53 (0.40) MAPTTP53ALDH1A1TSHRPSEN1
SCHEMBL4911999 0.84 PSEN1 (0.40) MAPTTP53ALDH1A1TSHRPSEN1
SCHEMBL4902470 0.83 TP53 (0.43) MAPTTP53ALDH1A1TSHRLMNA
SCHEMBL4899849 0.82 LMNA (0.46) MAPTTP53ALDH1A1TSHRLMNA
SCHEMBL4904147 0.81 ALDH1A1 (0.45) MAPTTP53ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MAPT 1858/4885TP53 3260/4885ALDH1A1 2664/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MAPT 1786/4885TP53 3421/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.